Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver

Human Pathology

Volumn 43, Issue 5, 2012, Pages 695-701

  Levy, Mary ^a,j   Trivedi, Anand ^a   Zhang, Jun ^b   Miles, Lili ^c   Mattis, Aras N ^d   Kim, Grace E ^d   Lassman, Charles ^e   Anders, Robert A ^f   Misdraji, Joseph ^g   Yerian, Lisa M ^h   Xu, Haodong ⁱ   Dhall, Deepti ^a   Wang, Hanlin L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^j CARIS LIFE SCIENCES   (United States)

more..

Author keywords

Glypican 3; Immunohistochemistry; Liver; Mesenchymal hamartoma; Undifferentiated embryonal sarcoma

Indexed keywords

GLYPICAN 3;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; LIVER MESENCHYMAL HAMARTOMA; LIVER TUMOR; MALE; OBSTRUCTIVE JAUNDICE; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR VOLUME; UNDIFFERENTIATED EMBRYONAL SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GLYPICANS; HAMARTOMA; HEPATOCYTES; HUMANS; INFANT; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84859898809     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.06.016     Document Type: Article

References (28)

1. Siddiqui MA, McKenna BJ. Hepatic mesenchymal hamartoma: a short review. Arch Pathol Lab Med 2006;130:1567-9. (Pubitemid 44520729)
2. Klaassen Z, Paragi PR, Chamberlain RS. Adult mesenchymal hamartoma of the liver: case report and literature review. Case Rep Gastroenterol 2010;4:84-92.
3. Cook JR, Pfeifer JD, Dehner LP. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. HUM PATHOL 2002;33:893-8.
4. Yesim G, Gupse T, Zafer U, et al. Mesenchymal hamartoma of the liver in adulthood: immunohistochemical profiles, clinical and histopathological features in two patients. J Hepatobiliary Pancreat Surg 2005;12:502-7. (Pubitemid 43124447)
5. Lauwers GY, Grant LD, Donnelly WH, et al. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 1997;21:1248-54.
6. Shehata B, Gupta NA, Katzenstein H, et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol 2011;14:111-6.
7. Kiani B, Ferrell LD, Qualman S, et al. Immunohistochemical analysis of embryonal sarcoma of the liver. Appl Immunohistochem Mol Morphol 2006;14:193-7. (Pubitemid 43941184)
8. Wei ZG, Tang LF, Chen ZM, et al. Childhood undifferentiated embryonal liver sarcoma: clinical features and immunohistochemistry analysis. J Pediatr Surg 2008;43:1912-9.
9. Lenze F, Birkfellner T, Lenz P, et al. Undifferentiated embryonal sarcoma of the liver in adults. Cancer 2008;112:2274-82. (Pubitemid 351628639)
10. Tokunaga Y, Ryo J, Hoppou T, et al. Hepatic undifferentiated (embryonal) sarcoma in an adult: a case report and review of the literature. Eur J Gastroenterol Hepatol 2000;12:1247-51.
11. Zheng JM, Tao X, Xu AM. Primary and recurrent embryonal sarcoma of the liver: clinicopathological and immunohistochemical analysis. Histopathology 2007;51:195-203. (Pubitemid 47083990)
12. Jakubovic BD, Jothy S. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma. Exp Mol Pathol 2007;82:184-9. (Pubitemid 46486730)
13. Ishiguro T, Sugimoto M, Kinoshita Y, et al. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res 2008;68:9832-8.
14. Nakano K, Orita T, Nezu J, et al. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2009;378:279-84.
15. Toretsky JA, Zitomersky NL, Eskenazi AE, et al. Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol 2001;23:496-9. (Pubitemid 33123699)
16. Zynger DL, Dimov ND, Luan C, et al. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol 2006;30:1570-5. (Pubitemid 44808793)
17. Capurro MI, Xiang YY, Lobe C, et al. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005;65:6245-54. (Pubitemid 40994410)
18. Zynger DL, Gupta A, Luan C, et al. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. HUM PATHOL 2008;39:224-30.
19. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006;12:1175-81.
20. Wang HL, Anatelli F, Zhai QJ, et al. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med 2008;132:1723-8.
21. Anatelli F, Chuang ST, Yang XJ, et al. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Am J Clin Pathol 2008;130:219-23.
22. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican-3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005;18:1591-8. (Pubitemid 41670658)
23. Coston WMP, Loera HT, Lau SK, et al. Distinction of hepatocellular carcinoma from benign mimickers using glypican-3 and CD34 immunohistochemistry. Am J Surg Pathol 2008;32:433-44. (Pubitemid 351398936)
24. Libbrecht L, Severi T, Cassiman D, et al. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006;30:1405-11. (Pubitemid 44655475)
25. Wang XY, Degos F, Dubois S, et al. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. HUM PATHOL 2006;37:1435-41. (Pubitemid 44739946)
26. Unal E, Koksal Y, Akcoren Z. Mesenchymal hamartoma of the liver mimicking hepatoblastoma. J Pediatr Hematol Oncol 2008;30:458-60.
27. Cajaiba MM, Sarita-Reyes C, Zambrano E, et al. Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels. Pediatr Dev Pathol 2007;10:233-8. (Pubitemid 350188042)
28. Boman F, Bossard C, Fabre M, et al. Mesenchymal hamartomas of the liver may be associated with increased serum alpha fetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg 2004;14:63-6.